Pharmacyclics Triggers Another Significant Milestone PaymentThe FINANCIALThe FINANCIAL — Pharmacyclics announced that the international, randomized Phase III clinical trial of ibrutinib in combination with bendamustine and rituximab in patients with r…
San Francisco ChronicleRoche cancer drugs and currency drive sales growthPharma TimesThe firm's top-selling drug was MabThera/Rituxan (rituximab), approved for non-Hodgkin's lymphoma and chronic lymphocytic leukaemia as well as rheumatoid arthr…
Safety Issue Puts Daclizumab in Doubt for MSMedPage TodayLYON, France — Daclizumab, a biologic drug targeting the interleukin-2 pathway, showed sustained efficacy in the second year of a phase II trial in multiple sclerosis, but serious autoimmune iss…
J&J keeps cash flowing on blockbuster Pharmacyclics deal for ibrutinibFierceBiotech… up with its third $50 million payday for the Btk inhibitor as the fifth patient with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lympho…
Pharmacyclics® Triggers Another Significant Milestone Payment for Phase III …Equities.comSUNNYVALE, Calif., Oct. 15, 2012 /PRNewswire/ — Pharmacyclics, Inc. (Nasdaq: PCYC) announced today that the international, randomized Phase III clinical trial …
Pharmacyclics gets $50M milestone payment from J&JMarketWatchThe trial involves Pharmacyclics's drug ibrutinib in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocy…
Pharmacyclics® Triggers Another Significant Milestone Payment for Phase III …Sacramento BeeSUNNYVALE, Calif., Oct. 15, 2012 — /PRNewswire/ — Pharmacyclics, Inc. (Nasdaq: PCYC) announced today that the international, randomized Phase III clinical t…
Biogen sees bright future in MS combo therapiesPharma TimesHe also highlighted the progress being made on a pegylated version of its blockbuster Avonex (interferon beta-1a) and Abbott-partnered daclizumab,. Asked which of the current pipeline compounds…
Weiger surviving the worst surrounded by family, friends, faithSuburban Life PublicationsDoctors now are trying an intravenous medication called Rituximab given to Johnny once a week for four weeks. He received his second dose this week. The medication…
Antikörpertherapie: Frauen reagieren besserDocCheck NewsDie Studie hat ergeben, dass der Blutspiegel (Serumspiegel) bei den Frauen über den Zeitraum der Therapie mit Rituximab um 20 Prozent höher ist als bei Männern. Frauen erreichen die Sättigung…